Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein tyrosine phosphatase receptor type C-associated protein (PTPRCAP) is a transmembrane phosphoprotein found predominantly in lymphocytes[1][4][5][7]. It physically associates with the CD45 (PTPRC) receptor, a critical protein tyrosine phosphatase that governs T- and B-cell activation in the immune system. PTPRCAP is required for the stable expression of CD45 and enhances its enzymatic activity, indirectly modulating Src family kinase phosphorylation and signaling events that drive cell proliferation, migration, and adhesion[1][2]. Genetic variation in PTPRCAP, particularly SNPs within its promoter region, has been linked to increased risk for diffuse-type gastric cancer by upregulating its expression and thereby enhancing downstream oncogenic signaling[2]. However, PTPRCAP itself is not an enzyme, receptor, or classical drug target, functioning as an accessory/regulatory component of the CD45 complex in lymphocyte signaling[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein tyrosine phosphatase receptor type C-associated protein (PTPRCAP).